News

Precision medicine trial will open to patient enrollment in July.

Company expects its FDA submission for the ARIES platform in the summer of 2015.

Recent breakthrough will make the blueprinting process faster, easier and cheaper, and should have major implications in the field of drug discovery and development.

Illumina today announced the formation of the Global Fertility Alliance, a new collaboration to advance excellence in fertility technologies and processes within the assisted reproductive treatment laboratory.

Show combination of ipilimumab and nivolumab or nivolumab alone increase progression-free survival in advanced melanoma patients.

A protein associated with many kinds of cancer cells was found to suppress the circadian clock, with implications for cancer biology and the workings of the clock itself.

Company expands their ongoing investment with the opening of their new UK Office in Swindon.

This paper sets out the factors that should be considered in seeking good performance from microflow cells for organic electrosynthesis.

Janssen Pharmaceutical has furthered its strategic partnership with the Rutgers University School of Engineering by providing $6 million to expand research that will help pharmaceutical companies develop new ways to manufacture prescription medicines.

Tim Jamison, professor of chemistry, MIT, and Aaron Beeler, assistant professor of chemistry, Boston University, have launched of Snapdragon Chemistry, Inc., to help companies harness the advantages and opportunities of continuous flow synthesis.